Please assess the completion status of the following clinical trial:

Trial Title: Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* HbA1C of 5.7% to 9.0% or a fasting blood glucose of greater than or equal to 100~* Participants that are diabetic should be stable on medications for at least 3 months prior to entering the study~* Neuropathy is most likely caused by impaired glucose regulation determined by medical or family history~* Autonomic neuropathy as defined by Toronto Neuropathy Expert Group 2010/2011 consensus criteria~* Medically stable at time of enrollment as determined by screening process~Exclusion Criteria:~* Neuropathy due to factors other than impaired glucose regulation determined by screening process~* Other severe medical illness or condition that would preclude safe participation in the study as determined by the study team~* Severe Autonomic Neuropathy that would limit study participation~* Musculoskeletal limitations that would preclude participation in balance assessment of protective stepping

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Muscle, Balance, and aerobic exercise (Type: EXPERIMENTAL): This trial will have a single experimental arm that will include the following interventions: Leg muscle strengthening, balance training using balance perturbations, and aerobic exercise. All individuals in this trial will receive all interventions listed.

Based on this trial design, predict the completion outcome and termination type (if applicable).